A Weil team advised Goldman Sachs in providing $9.1 billion of fully committed bridge financing to Becton Dickinson & Co., a leading medical technology company, to finance its $12.2 billion acquisition of CareFusion Corp., a global healthcare company that provides products and services to hospitals. The transaction, which is expected to close in the first half of 2015, will create a global leader in medication management and patient safety solutions.
The Weil team advising Goldman Sachs was led by Banking & Finance partner Morgan Bale, Capital Markets partner Jennifer Bensch and M&A partner Raymond Gietz, and included Real Estate partner Beatriz Azcuy-Diaz (Miami); Tax partner William Horton; Technology & IP Transactions partner Jeffrey Osterman; Litigation partners Robert Berezin, Chip Roh (Washington, DC) and Steven Tyrrell (Washington, DC); Environmental counsel John O’Loughlin (Washington, DC); Executive Compensation & Employee Benefits counsel Jeffrey Lieberman (Washington, DC); Litigation counsel Lawrence Baer; Banking & Finance associates Heather Viets and Rachel Trudeau; Capital Markets associate Jessica Wang; M&A associate Jennifer Cheng; Tax associate William Dong; Technology & IP Transactions associate Claudia Hoeben; Litigation associates Aryeh Zuber, Greg Kau, Erin Yates (Washington, DC), Eileen Citron (Washington, DC) and Robert Swenson; Environmental associate Thomas Goslin (Washington, DC); and Executive Compensation & Employee Benefits associate Brian Hamano (all in New York unless otherwise specified).
Source: www.weil.com
